These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15354417)
1. Effect of all-trans retinoic acid on telomerase activity in ovarian cancer cells. Purev E; Soprano DR; Soprano KJ J Exp Clin Cancer Res; 2004 Jun; 23(2):309-16. PubMed ID: 15354417 [TBL] [Abstract][Full Text] [Related]
2. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma. Kunisada M; Budiyanto A; Bito T; Nishigori C; Ueda M Br J Dermatol; 2005 Mar; 152(3):435-43. PubMed ID: 15787811 [TBL] [Abstract][Full Text] [Related]
3. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Ding Z; Green AG; Yang X; Chernenko G; Tang SC; Pater A Exp Cell Res; 2002 Jan; 272(2):185-91. PubMed ID: 11777343 [TBL] [Abstract][Full Text] [Related]
4. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells. Mano Y; Shimizu T; Tanuma S; Takeda K Anticancer Res; 2000; 20(3A):1649-52. PubMed ID: 10928085 [TBL] [Abstract][Full Text] [Related]
5. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621 [TBL] [Abstract][Full Text] [Related]
6. Vitamin E suppresses telomerase activity in ovarian cancer cells. Bermudez Y; Ahmadi S; Lowell NE; Kruk PA Cancer Detect Prev; 2007; 31(2):119-28. PubMed ID: 17335992 [TBL] [Abstract][Full Text] [Related]
7. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113). Zhang P; Xu Q; Chen WT; Duan LQ; Zhang ZY; Zhou XJ Oral Oncol; 2005 Oct; 41(9):909-15. PubMed ID: 16051514 [TBL] [Abstract][Full Text] [Related]
8. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]. Song Y; Kong BH; Liu PS; Ma DX; Jiang S Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708 [TBL] [Abstract][Full Text] [Related]
9. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399 [TBL] [Abstract][Full Text] [Related]
10. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation. Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943 [TBL] [Abstract][Full Text] [Related]
11. Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid. Ravikumar S; Perez-Liz G; Del Vale L; Soprano DR; Soprano KJ Cancer Res; 2007 Oct; 67(19):9266-75. PubMed ID: 17909034 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of telomerase limits the growth of human cancer cells. Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820 [TBL] [Abstract][Full Text] [Related]
13. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells. Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656 [TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells. Hayashidani Y; Hiyama E; Murakami Y; Sueda T Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061 [TBL] [Abstract][Full Text] [Related]
16. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells. Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906 [TBL] [Abstract][Full Text] [Related]
17. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells. Luo Y; Yi Y; Yao Z Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010 [TBL] [Abstract][Full Text] [Related]
18. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity. Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Koyanagi Y; Kobayashi D; Yajima T; Asanuma K; Kimura T; Sato T; Kida T; Yagihashi A; Kameshima H; Watanabe N Anticancer Res; 2000; 20(2A):773-8. PubMed ID: 10810353 [TBL] [Abstract][Full Text] [Related]
20. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer. Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]